Cite
White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.
MLA
Morotti, Andrea, et al. “White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.” Neurocritical Care, vol. 32, no. 1, Feb. 2020, pp. 180–86. EBSCOhost, https://doi.org/10.1007/s12028-019-00761-0.
APA
Morotti, A., Shoamanesh, A., Oliveira-Filho, J., Schlunk, F., Romero, J. M., Jessel, M., Ayres, A., Vashkevich, A., Schwab, K., Cassarly, C., Martin, R. H., Greenberg, S. M., Qureshi, A. I., Rosand, J., Goldstein, J. N., & Antihypertensive Treatment of Acute Cerebral Hemorrhage 2 (ATACH-2) and the Neurological Emergencies Treatment Trials (NETT) Network Investigators. (2020). White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial. Neurocritical Care, 32(1), 180–186. https://doi.org/10.1007/s12028-019-00761-0
Chicago
Morotti, Andrea, Ashkan Shoamanesh, Jamary Oliveira-Filho, Frieder Schlunk, Javier M. Romero, Michael Jessel, Alison Ayres, et al. 2020. “White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.” Neurocritical Care 32 (1): 180–86. doi:10.1007/s12028-019-00761-0.